A SIMPLE KEY FOR ABBV-744 BRD4 INHIBITION IN CANCER CELL LINES UNVEILED

In Phase A, members will obtain various doses and schedules of oral ABBV-744 pill to establish Secure dosing program. More members is going to be enrolled on the identified monotherapy dosign routine. In Segment B, members will acquire oral ruxolitinib and ABBV-744 are going to be supplied as "incorporate-on" therapy. In Phase C, members will recei